Fusion Antibodies plc (AIM:FAB)
London · Delayed Price · Currency is GBP · Price in GBX 13.16
-0.10 (-0.72%)
Jan 22, 2026, 4:26 PM GMT
Fusion Antibodies Market Cap
Fusion Antibodies has a market cap or net worth of 15.06 million as of January 22, 2026. Its market cap has increased by 72.47% in one year.
Market Cap
15.06M
Enterprise Value
15.20M
Revenue
1.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.16
Market Cap Chart
Since December 18, 2017, Fusion Antibodies's market cap has decreased from 27.28M to 15.06M, a decrease of -44.80%. That is a compound annual growth rate of -7.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 15.34M | -3.57% |
| Dec 31, 2025 | 15.91M | 135.22% |
| Dec 31, 2024 | 6.76M | 167.72% |
| Dec 29, 2023 | 2.53M | -78.42% |
| Dec 30, 2022 | 11.71M | -59.09% |
| Dec 31, 2021 | 28.62M | -9.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ondine Biomedical | 35.54M |
| ImmuPharma | 33.68M |
| Poolbeg Pharma | 32.42M |
| Arecor Therapeutics | 31.15M |
| Sareum Holdings | 26.92M |
| Aptamer Group | 24.27M |
| Oxford BioDynamics | 12.01M |
| IXICO | 10.66M |